Tonix Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 9, 2026
BERKELEY HEIGHTS, N.J., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) ("Tonix" or the "Company"), a fully integrated, commercial-stage biotechnology company, today announced that it will host a conference call and webcast to report third quarter 2026 financial results and operational highlights on Monday, November 9, 2026, at 8:30 a.m. ET.
Covered in this story
Call it yourself
No calls on $TNXP yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Tonix Pharmaceuticals Holding Corp →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.